Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat with Carboplatin and Paclitaxel in Advanced NSCLC
NCT01413750Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Nov 2010
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Nov 2010; status: terminated.
02
Drugs
vorinostat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01413750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01413750.